⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL82375 | 0.76 | — | — | |
| SCHEMBL7857348 | 0.73 | — | — | |
| SCHEMBL7857366 | 0.73 | — | — | |
| SCHEMBL6199090 | 0.71 | — | — | |
| SCHEMBL14960300 | 0.71 | — | — | |
| SCHEMBL13557174 | 0.69 | TSHR (0.33) | — | |
| SCHEMBL765060 | 0.67 | — | — | |
| Phosphonic Acid SCHEMBL8956311 | 0.67 | — | — | |
| SCHEMBL4173583 | 0.67 | — | — | |
| SCHEMBL726667 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024126842-A1 | NOVEL COMPOUNDS FOR DIAGNOSIS | AC IMMUNE SA (CH) | 2024-06-20 | — | — | WO | disclosed |
| WO-2024126840-A1 | NOVEL COMPOUNDS FOR DIAGNOSIS | AC IMMUNE SA (CH) | 2024-06-20 | — | — | WO | disclosed |
| EP-4206180-A1 | FLUORINE-CONTAINING ALKYL AMMONIUM BORATE COMPOUND AND METHOD FOR PRODUCING SAME | AGC INC. (JP) | 2023-07-05 | — | — | EP | disclosed |
| US-20230183393-A1 | FLUORINE-CONTAINING ALKYL AMMONIUM BORATE COMPOUND AND METHOD FOR PRODUCING SAME | AGC Inc. (JP) | 2023-06-15 | — | — | US | disclosed |
| WO-2023084000-A1 | 4H-IMIDAZO[1,5-B]PYRAZOLE DERIVATIVES FOR DIAGNOSIS | AC IMMUNE SA (CH) | 2023-05-19 | — | — | WO | disclosed |
| WO-2023083998-A1 | DIHYDROPYRROLO[3,4C]-PYRAZOLE DERIVATIVES AND THEIR USE IN DIAGNOSIS | AC IMMUNE SA (CH) | 2023-05-19 | — | — | WO | disclosed |
| WO-2023083961-A1 | DIHYDROPYRROLO[3,4-C]PYRAZOLE DERIVATIVES AND THEIR USE IN DIAGNOSIS | AC IMMUNE SA (CH) | 2023-05-19 | — | — | WO | disclosed |
| WO-2023054626-A1 | CYCLOPROPANAMIDE DERIVATIVE | 住友ファーマ株式会社 | 2023-04-06 | — | — | WO | disclosed |
| US-20230028045-A1 | NOVEL BORATE COMPOUND-CONTAINING COMPOSITION | AGC Inc. (JP) | 2023-01-26 | — | — | US | disclosed |
| EP-4119533-A1 | NOVEL BORATE COMPOUND-CONTAINING COMPOSITION | AGC INC. (JP) | 2023-01-18 | — | — | EP | disclosed |
| WO-2007006566-A1 | PYRIDAZINE COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 INHIBITORS | ABBOTT GMBH & CO. KG (DE) | 2007-01-18 | — | — | WO | disclosed |
| WO-2006040177-A1 | 6-AMINO(AZA)INDANE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECPTOR | ABBOTT GMBH & CO.KG (DE) | 2006-04-20 | — | — | WO | disclosed |
| WO-2006040180-A1 | AMINOMETHYL SUBSTITUTED BICYCLIC AROMATIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR | ABBOTT GMBH & CO. KG (DE) | 2006-04-20 | — | — | WO | disclosed |
| WO-2006040182-A1 | HETEROCYCLIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR | ABBOTT GMBH & CO. KG (DE) | 2006-04-20 | — | — | WO | disclosed |
| WO-2006040178-A1 | ARYLSULFONYLMETHYL OR ARYLSULFONAMIDE SUBSTITUTED AROMATIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MADULATION OF THE DOPAMINE D3 RECEPTOR | ABBOTT GMBH & CO.KG (DE) | 2006-04-20 | — | — | WO | disclosed |
| WO-2006040176-A1 | AZABICYCLOHEPTYL COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR | ABBOTT GMBH & CO. KG (DE) | 2006-04-20 | — | — | WO | disclosed |
| WO-2006040179-A1 | AMINOETHYLAROMATIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR | ABBOTT GMBH & CO. KG (DE) | 2006-04-20 | — | — | WO | disclosed |
| US-6254941-B1 | HIGH VOLTAGE HOLDING RATIO; LOW TEMPERATURE | CHISSO CORPORATION (JP) | 2001-07-03 | — | — | US | disclosed |
| EP-0950651-A1 | FLUOROALKYLATED LIQUID-CRYSTAL COMPOUNDS, LIQUID-CRYSTAL COMPOSITIONS, AND LIQUID-CRYSTAL DISPLAY ELEMENTS | CHISSO CORPORATION (JP) | 1999-10-20 | — | — | EP | disclosed |
| CN-1036578-A | NOVEL FLUOROPHOSPHONATE NUCLEOTIDE DERIVATIVES | MERRELL DOW PHARMA (US) | 1989-10-25 | — | — | CN | disclosed |